VC
Value Add VC
⚡HomePulse⚡Helpful Apps📝Blog🤝Partner
← Pulse/Companies

Goldman Sachs Alternatives on Pulse

Investor

The full thread of our Goldman Sachs Alternatives coverage — a running record of every development we've tracked, with the VC take on each.

2
Stories
2
With a headline figure
Jul 13, 2026
Since

Coverage Timeline

newest first
  1. Jul 29, 2026IPOGoldman-Backed Attovia Seeks $212.5M in Biotech IPO$212.5M IPO→
  2. Jul 13, 2026FUNDINGHelsing Raises $1.8B, Europe's Biggest Defense Round$1.8B at $18B→

All Coverage

IPO· Jul 29, 2026

Goldman-Backed Attovia Seeks $212.5M in Biotech IPO

Illustration for: Goldman-Backed Attovia Seeks $212.5M in Biotech IPO
IPO$212.5M IPO

Goldman-Backed Attovia Seeks $212.5M in Biotech IPO

Attovia Therapeutics is seeking up to $212.5 million in a US IPO, offering 12.5 million shares at $15-$17 each, backed by Goldman Sachs Alternatives, Deep Track Capital, Frazier Life Sciences, and venBio.

Jul 29, 2026
FUNDING· Jul 13, 2026

Helsing Raises $1.8B, Europe's Biggest Defense Round

Illustration for: Helsing Raises $1.8B, Europe's Biggest Defense Round
FUNDING$1.8B at $18B

Helsing Raises $1.8B, Europe's Biggest Defense Round

Munich-based Helsing closed a $1.8 billion Series E at an $18 billion valuation, Europe's biggest-ever defense-tech round, with Goldman Sachs Alternatives, CPPIB and JPMorgan joining as new investors amid oversubscribed demand.

Jul 13, 2026
@Trace_Cohen·t@nyvp.com